Form 4: Revolution Medicines CFO Sells Shares for Tax Obligations

Revolution Medicines' Chief Financial Officer, Jack Anders, sold 3,104 shares of common stock to cover tax withholding obligations from restricted stock unit vesting.

Summary

• Jack Anders, Chief Financial Officer of Revolution Medicines, Inc. (RVMD), reported a sale of common stock.
• The transaction involved 3,104 shares of common stock.
• The shares were sold at a price of $77.0904 per share on December 16, 2025.
• The sale was executed pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023.
• The purpose of the sale was to satisfy tax withholding obligations upon the vesting of restricted stock units (RSUs) after July 15, 2023.
• Following this transaction, Jack Anders beneficially owns 108,065 shares of common stock.
• This beneficial ownership includes 175 shares acquired under the Issuer's Employee Stock Purchase Plan on November 30, 2025.
• It also includes 42,338 restricted stock units.

Sentiment

Score: 5

Explanation: The filing reports a routine, pre-planned insider stock sale for tax purposes, which is neutral in sentiment. It does not indicate any positive or negative operational or financial developments for the company.

Positives

• The transaction was pre-planned under a Rule 10b5-1 plan, indicating a structured approach to insider trading and reducing concerns about opportunistic selling.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

Insider sales, particularly those executed under a Rule 10b5-1 plan for tax withholding purposes, are common occurrences in publicly traded companies. These transactions are generally considered routine and do not typically signal a change in management's confidence in the company's long-term prospects, especially when pre-scheduled.

Comparison to Industry Standards

• This transaction is a standard Form 4 filing for an insider stock sale to cover tax obligations, a common practice across all industries for executives receiving equity compensation.
• It aligns with typical corporate governance practices for managing equity awards and tax liabilities, similar to what would be seen at comparable biotechnology or pharmaceutical companies.

Corporate Governance

Related Party Transactions

• The sale of common stock by Chief Financial Officer Jack Anders is a related party transaction, as it involves a key executive of Revolution Medicines, Inc.

Stakeholder Impact

• Shareholders: Minimal direct impact, as it's a routine tax-related sale by an insider. It does not reflect a change in the company's fundamentals or outlook.
• Management: The CFO is managing personal tax obligations related to equity compensation, a standard practice.

Key Dates

Keywords

Revolution Medicines, RVMD, Jack Anders, CFO, Insider Trading, Form 4, Stock Sale, Rule 10b5-1, Restricted Stock Units, Tax Withholding, Employee Stock Purchase Plan